Primary Focal Segmental Glomerulosclerosis
6 clinical trials · Condition
◉ Watch Primary Focal Segmental Glomerulosclerosis
| Record | Firm | Date |
|---|---|---|
| Study of WAL0921 in Patients With Glomerular Kidney Diseases (NCT06466135) | Walden Biosciences | 2024-07-02 |
| Circulating Factors in Nephrotic Syndrome (NCT06315504) | Iain Bressendorff | 2024-04-01 |
| Obinutuzumab in Primary FSGS (NCT04983888) | Mayo Clinic | 2021-11-17 |
| FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS) (NCT03422510) | Complexa, Inc. | 2018-04-15 |
| A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS (NCT01573533) | Mayo Clinic | 2013-10-01 |
| A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) (NCT01665391) | Genzyme, a Sanofi Company | 2012-08-01 |
Track Primary Focal Segmental Glomerulosclerosis automatically
Every clearance here is in the API, with alerts when new ones post.